vs

Side-by-side financial comparison of GERON CORP (GERN) and OneSpan Inc. (OSPN). Click either name above to swap in a different company.

OneSpan Inc. is the larger business by last-quarter revenue ($62.9M vs $47.2M, roughly 1.3× GERON CORP). OneSpan Inc. runs the higher net margin — 69.2% vs -39.0%, a 108.2% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 2.9%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs -1.5%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.

GERN vs OSPN — Head-to-Head

Bigger by revenue
OSPN
OSPN
1.3× larger
OSPN
$62.9M
$47.2M
GERN
Growing faster (revenue YoY)
GERN
GERN
+64.2% gap
GERN
67.1%
2.9%
OSPN
Higher net margin
OSPN
OSPN
108.2% more per $
OSPN
69.2%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
-1.5%
OSPN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GERN
GERN
OSPN
OSPN
Revenue
$47.2M
$62.9M
Net Profit
$-18.4M
$43.5M
Gross Margin
73.6%
Operating Margin
-29.4%
19.9%
Net Margin
-39.0%
69.2%
Revenue YoY
67.1%
2.9%
Net Profit YoY
30.3%
51.3%
EPS (diluted)
$-0.03
$1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
OSPN
OSPN
Q4 25
$62.9M
Q3 25
$47.2M
$57.1M
Q2 25
$49.0M
$59.8M
Q1 25
$39.6M
$63.4M
Q4 24
$61.2M
Q3 24
$28.3M
$56.2M
Q2 24
$882.0K
$60.9M
Q1 24
$304.0K
$64.8M
Net Profit
GERN
GERN
OSPN
OSPN
Q4 25
$43.5M
Q3 25
$-18.4M
$6.5M
Q2 25
$-16.4M
$8.3M
Q1 25
$-19.8M
$14.5M
Q4 24
$28.8M
Q3 24
$-26.4M
$8.3M
Q2 24
$-67.4M
$6.6M
Q1 24
$-55.4M
$13.5M
Gross Margin
GERN
GERN
OSPN
OSPN
Q4 25
73.6%
Q3 25
73.6%
Q2 25
73.5%
Q1 25
74.3%
Q4 24
74.0%
Q3 24
73.9%
Q2 24
66.2%
Q1 24
73.1%
Operating Margin
GERN
GERN
OSPN
OSPN
Q4 25
19.9%
Q3 25
-29.4%
14.4%
Q2 25
-25.4%
17.6%
Q1 25
-42.2%
27.1%
Q4 24
19.3%
Q3 24
-99.8%
20.0%
Q2 24
-7860.9%
12.5%
Q1 24
-18465.1%
21.8%
Net Margin
GERN
GERN
OSPN
OSPN
Q4 25
69.2%
Q3 25
-39.0%
11.4%
Q2 25
-33.4%
13.9%
Q1 25
-50.1%
22.9%
Q4 24
47.1%
Q3 24
-93.5%
14.7%
Q2 24
-7639.8%
10.8%
Q1 24
-18220.4%
20.8%
EPS (diluted)
GERN
GERN
OSPN
OSPN
Q4 25
$1.13
Q3 25
$-0.03
$0.17
Q2 25
$-0.02
$0.21
Q1 25
$-0.03
$0.37
Q4 24
$0.73
Q3 24
$-0.04
$0.21
Q2 24
$-0.10
$0.17
Q1 24
$-0.09
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
OSPN
OSPN
Cash + ST InvestmentsLiquidity on hand
$78.1M
$70.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$248.7M
$271.8M
Total Assets
$567.4M
$397.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
OSPN
OSPN
Q4 25
$70.5M
Q3 25
$78.1M
$85.6M
Q2 25
$77.7M
$92.9M
Q1 25
$83.7M
$105.2M
Q4 24
$83.2M
Q3 24
$60.3M
$77.5M
Q2 24
$116.9M
$63.8M
Q1 24
$189.8M
$63.9M
Stockholders' Equity
GERN
GERN
OSPN
OSPN
Q4 25
$271.8M
Q3 25
$248.7M
$238.3M
Q2 25
$259.5M
$242.5M
Q1 25
$268.2M
$231.1M
Q4 24
$212.5M
Q3 24
$292.3M
$194.6M
Q2 24
$306.7M
$178.6M
Q1 24
$344.9M
$170.9M
Total Assets
GERN
GERN
OSPN
OSPN
Q4 25
$397.7M
Q3 25
$567.4M
$343.5M
Q2 25
$555.2M
$357.1M
Q1 25
$562.5M
$333.8M
Q4 24
$338.7M
Q3 24
$444.9M
$289.3M
Q2 24
$449.4M
$286.9M
Q1 24
$482.1M
$277.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
OSPN
OSPN
Operating Cash FlowLast quarter
$-13.6M
$12.6M
Free Cash FlowOCF − Capex
$9.6M
FCF MarginFCF / Revenue
15.3%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
0.29×
TTM Free Cash FlowTrailing 4 quarters
$50.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
OSPN
OSPN
Q4 25
$12.6M
Q3 25
$-13.6M
$11.3M
Q2 25
$-27.4M
$6.2M
Q1 25
$-48.0M
$29.4M
Q4 24
$12.4M
Q3 24
$-58.9M
$14.0M
Q2 24
$-53.5M
$2.3M
Q1 24
$-62.3M
$27.0M
Free Cash Flow
GERN
GERN
OSPN
OSPN
Q4 25
$9.6M
Q3 25
$8.8M
Q2 25
$4.4M
Q1 25
$27.7M
Q4 24
$10.5M
Q3 24
$12.0M
Q2 24
$-53.7M
$26.0K
Q1 24
$-62.9M
$23.9M
FCF Margin
GERN
GERN
OSPN
OSPN
Q4 25
15.3%
Q3 25
15.4%
Q2 25
7.3%
Q1 25
43.8%
Q4 24
17.1%
Q3 24
21.4%
Q2 24
-6086.6%
0.0%
Q1 24
-20680.3%
36.9%
Capex Intensity
GERN
GERN
OSPN
OSPN
Q4 25
4.7%
Q3 25
4.4%
Q2 25
3.1%
Q1 25
2.6%
Q4 24
3.2%
Q3 24
0.0%
3.5%
Q2 24
23.4%
3.7%
Q1 24
202.3%
4.7%
Cash Conversion
GERN
GERN
OSPN
OSPN
Q4 25
0.29×
Q3 25
1.74×
Q2 25
0.75×
Q1 25
2.02×
Q4 24
0.43×
Q3 24
1.69×
Q2 24
0.35×
Q1 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GERN
GERN

Segment breakdown not available.

OSPN
OSPN

Transferred At Point In Time$32.7M52%
Subscription$21.1M34%
Maintenance Support And Other$9.2M15%

Related Comparisons